Kericure Inc.
Dba Kericure Medical
Div Kericure Medical
CAGE Code: 692P8
NCAGE Code: 692P8
Status: Active
Type: Manufacturer
Dun & Bradstreet (DUNS): 966638681
Summary
Kericure Inc., Dba Kericure Medical, Div Kericure Medical is an Active Manufacturer with the Cage Code 692P8 and is tracked by Dun & Bradstreet under DUNS Number 966638681..
Address
24327 Oaks Blvd
Land O Lakes FL 34639-5618
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Tri-County Environmentl Labs Prime Construction & Development Dynamic Engineering D3s2 Llc Yellow Mountain Business Solutions Brooks Builders Llc J.P Sheds Llc X5msolutions Llc Aj's Power Source, Inc. Jenkins Business Forms Master Gss Usa Corp Zloty Consulting Llc Busing Company Inc Harris, Kay Conexus Technologies Inc D. C. Sparks Electric, Incorporated Dk Medical Administration Services Superior Forestry Services The Sherwin-Williams Company Land O'lakes Fish And Game Club, Inc
Frequently Asked Questions (FAQ) for CAGE 692P8
- What is CAGE Code 692P8?
- 692P8 is the unique identifier used by NATO Organizations to reference the physical entity known as Kericure Inc. Dba Kericure Medical Div Kericure Medical located at 24327 Oaks Blvd, Land O Lakes FL 34639-5618, United States.
- Who is CAGE Code 692P8?
- 692P8 refers to Kericure Inc. Dba Kericure Medical Div Kericure Medical located at 24327 Oaks Blvd, Land O Lakes FL 34639-5618, United States.
- Where is CAGE Code 692P8 Located?
- CAGE Code 692P8 is located in Land O Lakes, FL, USA.
Contracting History for CAGE 692P8 Most Recent 25 Records
- HT942523C0069
- Dha Sequential Phase Ii Sbir Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care
- 20 Sep 2023
- Dha Sequential Phase Ii Sbir Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care
- Army Med Res Acq Activity
- Department Of Defense (Dod)
- $1,299,857.19
- Department Of Defense (Dod)
- HT942523C0049
- Kericure, Inc. Dha Sbir Phase Iii Clinical Validation Of A Portable, Ruggedized Antimicrobial Wound Dressing In Management Of Large Surface Area Burns For Prolonged Field Care And Long-Term Care
- 20 Sep 2023
- Kericure, Inc. Dha Sbir Phase Iii Clinical Validation Of A Portable, Ruggedized Antimicrobial Wound Dressing In Management Of Large Surface Area Burns For Prolonged Field Care And Long-Term Care
- Army Med Res Acq Activity
- Department Of Defense (Dod)
- $3,111,212.00
- Department Of Defense (Dod)
- W911SR22P0003
- Phase I Sbir Research & Development Efforts Ruggedized Spray On Antimicrobial Wound Dressing For Treatment Of Multiple Sulfur Mustard-Induced Dermal Injuries In Theater To Mitigate Infection, Pain And Promote Healing
- 18 Feb 2022
- Phase I Sbir Research & Development Efforts Ruggedized Spray On Antimicrobial Wound Dressing For Treatment Of Multiple Sulfur Mustard-Induced Dermal Injuries In Theater To Mitigate Infection, Pain And Promote Healing
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $167,470.02
- Department Of Defense (Dod)
- W81XWH20C0112
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled: "Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care"
- 24 Sep 2020
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled: "Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care"
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,099,986.42
- Department Of Defense (Dod)
- W81XWH20C0112
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled:"Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care"-Revised Statement Of Work
- 10 Jun 2021
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled:"Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care"-Revised Statement Of Work
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $1,099,986.42
- Department Of Defense (Dod)
- W81XWH20C0112
- Per Section 711 Of 2019 Ndaa, Usamraa Transferred To Dha 10/1/2022. Dha Sbir Direct To Phase Ii - H2d-0023. P00003 Reflects Subcontractor And Dodaac Changes.
- 15 Dec 2022
- Per Section 711 Of 2019 Ndaa, Usamraa Transferred To Dha 10/1/2022. Dha Sbir Direct To Phase Ii - H2d-0023. P00003 Reflects Subcontractor And Dodaac Changes.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $2,199,745.37
- Department Of Defense (Dod)
- W81XWH20C0112
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled: "Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care" - Award Phiie And Phiii
- 24 Mar 2022
- Dha 2020.1 Sbir Direct To Phase Ii Medical R&D Contract For Proposal #H2d-0023, Titled: "Deployable Wound Care Products To Decrease Preventable Death Outcomes By Mitigating Infection On Battlefield And Through Long Term Care" - Award Phiie And Phiii
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $2,199,745.37
- Department Of Defense (Dod)